Literature DB >> 32709732

Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI.

Hicham Skali1,2, Venkatesh L Murthy3, Diana Paez4, Elisa M Choi5, Felix Y J Keng6, McGhie A Iain7, Mouaz Al-Mallah8, Roxana Campisi9, Timothy M Bateman7, Ignasi Carrio10, Rob Beanlands11, Dennis A Calnon12, Vasken Dilsizian13, Maurizio Dondi4, Alessia Gimelli14, Robert Pagnanelli15, Donna M Polk2, Prem Soman16, Andrew J Einstein17, Sharmila Dorbala1,2, Randall C Thompson18.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32709732     DOI: 10.2967/jnumed.120.251355

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  3 in total

Review 1.  A comprehensive review of imaging findings in COVID-19 - status in early 2021.

Authors:  Ali Afshar-Oromieh; Helmut Prosch; Cornelia Schaefer-Prokop; Karl Peter Bohn; Ian Alberts; Clemens Mingels; Majda Thurnher; Paul Cumming; Kuangyu Shi; Alan Peters; Silvana Geleff; Xiaoli Lan; Feng Wang; Adrian Huber; Christoph Gräni; Johannes T Heverhagen; Axel Rominger; Matthias Fontanellaz; Heiko Schöder; Andreas Christe; Stavroula Mougiakakou; Lukas Ebner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-01       Impact factor: 9.236

2.  The Cardiovascular Imaging Community's Response to the COVID-19 Pandemic.

Authors:  Randall C Thompson; Kyle R Lehenbauer
Journal:  JACC Cardiovasc Imaging       Date:  2021-06-16

3.  Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.

Authors:  Jonathan Vigne; Damien Peyronnet; Julien Leenhardt; Constance Dubegny; Valérie Ardisson; Guillaume Pariscoat; Claire Bolot; Aurore Rauscher; François Hallouard; Caroline Clave-Darcissac; Anthony Clotagatide; Emmanuel Odouard; Alain Faivre-Chauvet; Justine Diehl; Benjamin Houdu; Denis Agostini; Rémy Morello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-24       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.